• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    |
    Weekly News Recap #Phispers
    US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

    US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

    Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

    Impressions : 1994

    Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market

    Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market

    In news this week, Sanofi is considering the sale of its consumer health unit and has received binding bids valuing the divisi...

    Impressions : 1512

    Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA

    Astra’s cancer drugs impress at ASCO; Moderna’s mRESVIA becomes first mRNA RSV vaccine approved by FDA

    This week saw the American Society of Clinical Oncology (ASCO) annual meeting in Chicago where cancer researchers presented det...

    Impressions : 1231

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.